Novel therapies being developed by IMI-funded researchers could help to prevent and cure rheumatoid arthritis by tackling the autoimmune disease in the very early stages, before debilitating symptoms appear.
New open access tools for drug development, obesity, and the environmental impacts of medicines are the focus of a new Innovative Medicines Initiative Call for proposals.
Commission R&D funding for neglected diseases rose by 50 per cent in 2017. The UK and US remain the biggest funders - and UK spending increased by 89 per cent, says Australian charity